Literature DB >> 19108815

Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice.

Pamela W Klein1, Judith D Easterbrook, Erin N Lalime, Sabra L Klein.   

Abstract

BACKGROUND: Previous data from our laboratory suggest that gonadally intact C57BL/6 male mice are more likely than their female counterparts to die from Plasmodium chabaudi infection, to recover more slowly from weight loss and hematocrit loss, and to have reduced interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) responses. Removal of the ovaries, and hence, the primary production of sex steroids in females, reverses these differences.
OBJECTIVE: We hypothesized that sex differences in response to P chabaudi may be mediated by differential synthesis of IFN-gamma and IL-10 that is influenced by estrogen, progesterone, or both.
METHODS: C57BL/6 female mice (n = 200; n = 10/time point/treatment/experiment) were ovariectomized and implanted with a 21-day controlled-release pellet containing either 0.1 mg of 17beta-estradiol (E(2)), 10 mg of progesterone (P(4)), 0.1 mg of E(2) plus 10 mg of P(4), or cholesterol (placebo). Females were inoculated with 10(6)P chabaudi-infected erythrocytes. Body mass, body temperature, hematocrit, parasitemia, cytokine production, and antibody responses were monitored 0, 3, 5, 7, 10, 14, and 21 days postinoculation.
RESULTS: Administration of E(2), either alone or in combination with P(4), mitigated infection-induced weight loss, hematocrit loss, and hypothermia, compared with females receiving placebo pellets (P < 0.05 in each case). Hormone treatment did not affect levels of parasitemia. Females administered E(2) alone or in combination with P(4) produced 4 to 7 times higher IFN-gamma and IL-10 during peak parasitemia than did females implanted with pellets containing either P(4) alone or placebo (P < 0.05 in each case). Exposure to E(2), either alone or in combination with P(4), increased anti-P chabaudi immunoglobulin G (IgG1) responses and the ratio of IgG1 to IgG2c (P < 0.05 in each case).
CONCLUSION: This animal study suggests that physiological levels of estrogen, rather than progesterone, enhance immunity and, possibly, protect females from disease symptoms during malaria infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108815      PMCID: PMC4155322          DOI: 10.1016/j.genm.2008.10.001

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  43 in total

1.  Female's heightened immune status: estrogen, T cells, and inducible nitric oxide synthase in the balance.

Authors:  Daniela Verthelyi
Journal:  Endocrinology       Date:  2006-02       Impact factor: 4.736

2.  Testosterone suppresses protective responses of the liver to blood-stage malaria.

Authors:  Jürgen Krücken; Mohamed A Dkhil; Juliane V Braun; Regina M U Schroetel; Manal El-Khadragy; Peter Carmeliet; Horst Mossmann; Frank Wunderlich
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Regulating immunity to malaria.

Authors:  E M Riley; S Wahl; D J Perkins; L Schofield
Journal:  Parasite Immunol       Date:  2006 Jan-Feb       Impact factor: 2.280

4.  Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma.

Authors:  Ebru Karpuzoglu; Jillian B Fenaux; Rebecca A Phillips; Andrea J Lengi; François Elvinger; S Ansar Ahmed
Journal:  Endocrinology       Date:  2005-11-17       Impact factor: 4.736

Review 5.  Hormonal modulation of B cell development and repertoire selection.

Authors:  Christine M Grimaldi; Latia Hill; Xiaonan Xu; Elena Peeva; Betty Diamond
Journal:  Mol Immunol       Date:  2005-05       Impact factor: 4.407

6.  Effect of estrogens on the interferon-gamma producing cell population of mouse splenocytes.

Authors:  Mako Nakaya; Hirofumi Tachibana; Koji Yamada
Journal:  Biosci Biotechnol Biochem       Date:  2006-01       Impact factor: 2.043

7.  Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.

Authors:  Rosana M F Libonati; Maristela G Cunha; José M Souza; Marcos V N Santos; Salma G Oliveira; Claudio T Daniel-Ribeiro; Leonardo J M Carvalho; José L M do Nascimento
Journal:  Neuroimmunomodulation       Date:  2006-05-12       Impact factor: 2.492

8.  Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection.

Authors:  Amy Cernetich; Lindsey S Garver; Anne E Jedlicka; Pamela W Klein; Nirbhay Kumar; Alan L Scott; Sabra L Klein
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

9.  Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion.

Authors:  Cherie L Butts; Shetha A Shukair; Kristina M Duncan; Eve Bowers; Cash Horn; Elena Belyavskaya; Leonardo Tonelli; Esther M Sternberg
Journal:  Int Immunol       Date:  2007-02-07       Impact factor: 4.823

Review 10.  Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity.

Authors:  Grant C Hughes; Edward A Clark
Journal:  Autoimmunity       Date:  2007-09       Impact factor: 2.815

View more
  14 in total

1.  Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques.

Authors:  Flora Engelmann; Alex Barron; Henryk Urbanski; Martha Neuringer; Steven G Kohama; Byung Park; Ilhem Messaoudi
Journal:  Age (Dordr)       Date:  2010-09-03

Review 2.  Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.

Authors:  Andrea L Hevener; Deborah J Clegg; Franck Mauvais-Jarvis
Journal:  Mol Cell Endocrinol       Date:  2015-05-29       Impact factor: 4.102

3.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

4.  Sex differences in opisthorchiosis and the development of cholangiocarcinoma in Syrian hamster model.

Authors:  Pakkayanee Sudsarn; Nadchanan Wongchalee; Thidarut Boonmars; Porntip Laummaunwai; Yaovaluk Chamgramol; Chawalit Pairojkul; Amornrat Juasook; Sirintip Boonjaraspinyo
Journal:  Parasitol Res       Date:  2013-12-07       Impact factor: 2.289

5.  Level of circulating steroid hormones in malaria and cutaneous leishmaniasis: a case control study.

Authors:  Farideh Esfandiari; Bahador Sarkari; Habibollah Turki; Nasir Arefkhah; Najme Shakouri
Journal:  J Parasit Dis       Date:  2018-11-20

6.  Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.

Authors:  Landon G Vom Steeg; Yevel Flores-Garcia; Fidel Zavala; Sabra L Klein
Journal:  Vaccine       Date:  2019-06-28       Impact factor: 3.641

Review 7.  The role of estrogens in control of energy balance and glucose homeostasis.

Authors:  Franck Mauvais-Jarvis; Deborah J Clegg; Andrea L Hevener
Journal:  Endocr Rev       Date:  2013-03-04       Impact factor: 19.871

8.  Gonadal steroids negatively modulate oxidative stress in CBA/Ca female mice infected with P. berghei ANKA.

Authors:  Néstor Aarón Mosqueda-Romo; Ana Laura Rodríguez-Morales; Fidel Orlando Buendía-González; Margarita Aguilar-Sánchez; Jorge Morales-Montor; Martha Legorreta-Herrera
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

9.  Micro-epidemiology of malaria in an elimination setting in Central Vietnam.

Authors:  Melanie Bannister-Tyrrell; Nguyen Xuan Xa; Johanna Helena Kattenberg; Nguyen Van Van; Vu Khac Anh Dung; Truong Minh Hieu; Nguyen Van Hong; Eduard Rovira-Vallbona; Nguyen Thanh Thao; Tran Thanh Duong; Anna Rosanas-Urgell; Koen Peeters Grietens; Annette Erhart
Journal:  Malar J       Date:  2018-03-19       Impact factor: 2.979

10.  IFNGR1 signaling is associated with adverse pregnancy outcomes during infection with malaria parasites.

Authors:  Mamoru Niikura; Shin-Ichi Inoue; Shoichiro Mineo; Hiroko Asahi; Fumie Kobayashi
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.